Kinled Overview

  • Investor Type
  • Family Office

  • Status
  • Active

  • Professionals
  • 4


  • Investments
  • 121

  • Portfolio
  • 95

  • Exits
  • 22


Kinled General Information

Company Description

Founded in 1924, Kinled is a family office based in Hong Kong. The firm seeks to invest in the life sciences, digitech, medtech, biomedical technology, medical devices, biopharmaceuticals, healthcare services, and financial technology industries.

Business Details

Year Founded
Investor Status
Actively Seeking New Investments
Trade Association
Swiss Private Equity & Corporate Finance (SWPE)
Primary Investor Type
Family Office
Corporate Office
  • 19-27 Wyndham Street, Central Hong Kong
  • Suite 902, Wilson House
  • Hong Kong
  • Hong Kong

Kinled Investments (121)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Memo Therapeutics 07-May-2024 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2
Lapse 27-Feb-2024 00000 00000 Social/Platform Software Generating Revenue
Bob W 13-Feb-2024 00000 00000 000.00 Hotels and Resorts Generating Revenue
Greyparrot 07-Feb-2024 00000 00000 000.00 Business/Productivity Software Generating Revenue
OctaiPipe 23-Jan-2024 00000 00000 00.000 Business/Productivity Software Generating Revenue
Vico Therapeutics 05-Jan-2024 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1
Druid 01-Dec-2023 00000 00000 0000 Business/Productivity Software Generating Revenue
Mytos 30-Nov-2023 00000 00000 0000 Biotechnology Generating Revenue
doctorly 09-Nov-2023 Later Stage VC 000.00 Enterprise Systems (Healthcare) Generating Revenue
MinervaX 11-Oct-2023 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 3
You’re viewing 10 of 121 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kinled Exits (22)

Company Name Exit Date Exit Type Exit Size
Hussle 27-Mar-2024 Merger/Acquisition
Herophilus 27-Sep-2023 000000000000000000
Zopa 08-Sep-2023 00000 00000 00 000.00
Vertus Capital (Private Equity) 21-Aug-2023 000000000000000000 00.000
Orchestra BioMed 26-Jan-2023 0000000 000000 0000
Acrivon Therapeutics 15-Nov-2022 000 000.00
Motley (Accessories) 01-Oct-2022 0000000000: 000000
GotCourts 01-Feb-2022 000000000000000000
Planetly 08-Oct-2021 Merger/Acquisition 00000
Corlieve Therapeutics 30-Jul-2021 Merger/Acquisition 00000
You’re viewing 10 of 22 exits. Get the full list »

Kinled Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Kinled Management, Team & Partners (4)

Name Title Deals Funds Boards Office
Thomas Lucy Partner 0 0 Hong Kong, Hong Kong
Rupert Novis Director 0 0 Hong Kong, Hong Kong
Nat Hutley Associate Hong Kong, Hong Kong
Iain Hubert Director Hong Kong, Hong Kong
To view Kinled’s complete team members history, request access »

Kinled Co-Investors (427)

Name With Exits Lead Partner Series Industry
Pureos Bioventures 13 0 0 Series chart Industry bar
Speedinvest 00 0 Series chart Industry bar
Verve Ventures 0 0 Series chart Industry bar
Concentric 0 0 0 Series chart Industry bar
EQT Life Sciences 0 0 Series chart Industry bar
You’re viewing 5 of 427 co-investors. Get the full list »

Kinled FAQs

  • What is Kinled?

    Founded in 1924, Kinled is a family office based in Hong Kong.

  • When was Kinled founded?

    Kinled was founded in 1924.

  • Where is Kinled headquartered?

    Kinled is headquartered in Hong Kong, Hong Kong.

  • How many investments has Kinled made?

    Kinled has made 121 investments.

  • What has Kinled invested in?

    Kinled has made numerous investments in companies like Memo Therapeutics, Lapse, and Bob W within the Drug Discovery, Social/Platform Software, and Hotels and Resorts industries.

  • What has Kinled invested in recently?

    Kinled's latest investment was on 07-May-2024 in Memo Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »